PAHC Phibro Animal Health · $33.31 Extended — don't chase; wait for a pullback过度拉升 — 勿追高;等待回撤 Terminal终端
Phibro Animal Health · Health Care

PAHC

$33.31
Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock.PhibroAnimalHealthCorporation是一家美国动物健康和矿物质营养公司,其产品包括抗菌药、抗球虫药、驱虫药,以及动物营养品和牲畜疫苗。
Rate-sensitive利率敏感
Engine stance引擎立场2026-07-20
Extended — don't chase; wait for a pullback过度拉升 — 勿追高;等待回撤
You missed the bottoming entry — the low already formed and price is now extended (momentum is fading — the daily moment已错过筑底入场——低点已经形成,目前价格已拉伸(动量正在衰竭——日线动量已开始掉头向下)。不要追高;等待回调至 10 日均线或下一个周期低点。若已持有则继续持有。
Open in Terminal打开终端 All coverage所有股票 Data through数据截至 2026-07-20 · regenerated nightly每日更新

Key Statistics关键统计

Price价格
$33.31
43.9% below 52-week high低于52周高点 43.9%
Beta贝塔
1.11
Moves about 1.1x the market波动幅度约为市场的 1.1 倍
RSI (14)RSI(14)
50
Neutral zone中性区域
Volatility Rank波动率分位
11th pctile
hist. vol. percentile历史波动率分位数

Performance价格表现

Period周期 PAHC S&P 500vs Index对比指数
1 Week近1周 +3.9% -1.5% Beat the index by 5.4 points跑赢指数 5.4 个百分点
1 Month近1月 +8.0% +0.6% Beat the index by 7.4 points跑赢指数 7.4 个百分点
3 Months近3月 -41.4% +4.7% Lagged the index by 46.1 points落后指数 46.1 个百分点
6 Months近6月 -18.4% +7.8% Lagged the index by 26.2 points落后指数 26.2 个百分点
Year to date年初至今 -10.1% +9.1% Lagged the index by 19.2 points落后指数 19.2 个百分点
1 Year近1年 +13.5% +19.4% Lagged the index by 5.9 points落后指数 5.9 个百分点
3 Years近3年 +149.3% +69.4% Beat the index by 79.9 points跑赢指数 79.9 个百分点

Technicals技术面

RSI (14)RSI(14) 50 Neutral zone中性区域
vs 50-day相对50日均线 -0.4% vs 50-day avg
vs 200-day相对200日均线 -21.7% vs 200-day avg
Volatility rank波动率分位 11th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$32.80
Don't chase above不追高于
$33.31
Stop止损
$30.53
Extended — wait for a pullback过度拉伸 — 等待回撤

Earnings财务业绩

Estimates being cut预期下调

Earnings call transcripts — coming soon财报电话会议记录 — 即将上线

Financials财务数据

Revenue营业收入
$800.4M
2020
$833.4M
2021
$942.3M
2022
$977.9M
2023
$1.0B
2024
$1.3B
2025
5yr CAGR5年复合增速: 10.1%
Earnings Per Share每股收益
$0.83
2020
$1.34
2021
$1.21
2022
$0.81
2023
$0.06
2024
$1.19
2025
5yr CAGR5年复合增速: 7.5%
Free Cash Flow自由现金流
$25.3M
2020
$19.0M
2021
-$5.4M
2022
-$38.5M
2023
$46.4M
2024
$41.8M
2025
Margins利润率
Gross margin毛利率
30.9%
Operating margin营业利润率
8.5%
Net margin净利率
3.7%
FCF margin自由现金流利润率
6.2%
14.5%Return on Equity股本回报率
3.4%Return on Assets资产回报率
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-0.44
Current ratio流动比率2.76
Piotroski皮奥特罗斯基 5/7 Clean稳健

Snapshot Gauges综合指标

Beta市场敏感度
1.11×
0.2
Moves about 1.1× the market波动幅度约为市场的 1.1 倍
Financial Health财务健康
5/7
Adequate financial health财务健康状况一般
Dividend分红
Does not pay a dividend不派发股息

Why Is It Moving为何波动

Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Insider cluster activity内部人集中交易
Technical技术面 NEARING A HIGH → BOTTOMING接近高点 → 筑底中

Ownership & Smart Money持仓与聪明钱

Insider activity内部人员活动: -$26.3M net (0 buyers, 2 sellers)-$26.3M 净值(0 买家,2 卖家)
Concentrated ownership集中持仓
Fund基金 Grade评级 Activity动作 % of portfolio组合占比 As of截至
Polen Capital Management B New position新建仓 0.0% 2026-03-31

Signal History信号历史

BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS. A daily bottoming setup did fire (swing low in, momentum turned up), but it's LATE — price is already extended above the cycle low (formed ~17 day(s) ago @ 30.53) and momentum is fading — the daily momentum is already rolling over. A momentum cross is a LAGGING confirmation: after a vertical run it only triggers once the move is mature, so the bottoming entry has already passed. This is a chase, not a fresh buy. Last cycle was left-translated (topped early) — a bearish structural tell止盈。日线筑底形态确实已经触发(摆动低点出现、动量转向上行),但为时已晚——价格已显著高于周期低点(约 17 天前形成 @ 30.53)且动量正在衰竭——日线动量已开始掉头向下。动量交叉属于滞后确认:在垂直拉升之后,只有当走势已经成熟时才会触发,因此筑底入场早已错过。这是追高,而非新的买入。 上一周期为左移结构(见顶偏早)——属于看空的结构性信号
TOP WATCH NEARING A HIGH
Jul 8, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 7, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 6, 2026
UNCONFIRMED TURN → BOTTOMING未确认转向 → 筑底中
BUY SETUP买入预备
Jul 1, 2026
NEARING A LOW → UPTREND接近低点 → 上涨趋势
HOLD持有
Jun 30, 2026
UPTREND → NEARING A LOW上涨趋势 → 接近低点
GET READY准备
Jun 30, 2026
PAHC broke down vs the marketPAHC 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $31.40.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$31.40。
Jun 25, 2026
NEARING A LOW → UPTREND接近低点 → 上涨趋势
HOLD持有
Jun 24, 2026
NEARING A LOW → UNCONFIRMED TURN接近低点 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作

Showing last 15 of显示最近15条,共 244 signals条信号

Factor Profile因子特征

Composite factor score综合因子得分: -0.57
Profitability盈利能力
-0.2
Quality质量
-0.8
Investment资本投入
-0.1
Low volatility低波动
-1.3
Low market beta低市场敏感度
-0.3
Earnings quality盈利质量
-0.4
Short interest空头兴趣
-0.3

Company Profile公司档案

Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock.PhibroAnimalHealthCorporation是一家美国动物健康和矿物质营养公司,其产品包括抗菌药、抗球虫药、驱虫药,以及动物营养品和牲畜疫苗。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
  • Inventory build
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析,覆盖所有标普500成分股。